We are live on !
Find out more
SRL
Scientech Research LLC Portfolio holdings
AUM
$123M
Turnover
94.02%
1-Year Est. Return
198.31%
This Fund
S&P 500
This Quarter Est. Return
+110.75%
1 Year Est. Return
+198.31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$3.5M
(+2.9%)
Cap. Flow
-$13M
Cap. Flow % of AUM
Cap. Flow %
-10.55%
Top 10 Holdings %
Top 10 Hldgs %
16.74%
Holding
635
New
186
Increased
16
Reduced
22
Closed
411
Avg Time Held
0.1
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Rex 2X Long MSTR Daily Target ETF
MSTU
|
+$3.39M |
| 2 |
Strategy Inc
MSTR
|
+$3.18M |
| 3 |
SpaceX
SPCX
|
+$2.07M |
| 4 |
Tesla
TSLA
|
+$1.91M |
| 5 |
Sable Offshore Corp
SOC
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Digital
APLD
|
+$1.63M |
| 2 |
Wave Life Sciences
WVE
|
+$1.45M |
| 3 |
EchoStar
ECHO
|
+$1.37M |
| 4 |
Leverage Shares 2X Long CRCL Daily ETF
CRCG
|
+$1.36M |
| 5 |
Viridian Therapeutics
VRDN
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.25% |
| 2 | Healthcare | 18.64% |
| 3 | Miscellaneous | 15.68% |
| 4 | Industrials | 11.04% |
| 5 | Financials | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Fulcrum Therapeutics
FULC
$283M
| $105K | 0.08% |
+28,584
| New | +$174K |
2026 Q2
0 quarters
|
|
177
GraniteShares 2x Long COIN Daily ETF
CONL
$481M
| $101K | 0.08% |
23,638
-128,887
| -85% | -$916K |
2025 Q3
3 quarters
|
|
178
C4 Therapeutics
CCCC
$356M
| $99.3K | 0.08% |
+21,260
| New | +$72.7K |
2026 Q2
0 quarters
|
|
179
GraniteShares 2x Long PLTR Daily ETF
PTIR
$361M
| $96.6K | 0.08% |
+10,295
| New | +$141K |
2026 Q2
0 quarters
|
|
|
HELP
180
Helus Pharma Inc. Common Stock
HELP
$781M
| $93.1K | 0.08% |
+14,081
| New | +$70.4K |
2026 Q2
0 quarters
|
|
181
LifeVantage
LFVN
$75.3M
| $92.7K | 0.08% |
+14,858
| New | +$90K |
2026 Q2
0 quarters
|
|
182
Eledon Pharmaceuticals
ELDN
$176M
| $90K | 0.07% |
+22,844
| New | +$83.1K |
2026 Q2
0 quarters
|
|
183
Veru
VERU
$39.4M
| $88.9K | 0.07% |
+28,391
| New | +$72.3K |
2026 Q2
0 quarters
|
|
184
Relmada Therapeutics
RLMD
$337M
| $81.8K | 0.07% |
11,826
-2,783
| -19% | -$19.4K |
2026 Q1
1 quarter
|
|
185
enGene Therapeutics
ENGN
$106M
| $70.4K | 0.06% |
+40,710
| New | +$166K |
2026 Q2
0 quarters
|
|
186
Optimum Communications Inc
OPTU
$344M
| $69.1K | 0.06% |
+47,659
| New | +$59.2K |
2026 Q2
0 quarters
|
|
187
Worksport
WKSP
$6.77M
| $69K | 0.06% |
+63,321
| New | +$57.5K |
2026 Q2
0 quarters
|
|
188
SAB Biotherapeutics
SABS
$237M
| $68K | 0.06% |
17,446
+6,630
| +61% | +$24.7K |
2026 Q1
1 quarter
|
|
189
Zentalis Pharmaceuticals
ZNTL
$218M
| $66K | 0.05% |
+13,613
| New | +$54.3K |
2026 Q2
0 quarters
|
|
190
STAK Inc
STAK
$19.2M
| $62.9K | 0.05% |
+16,508
| New | +$38.8K |
2026 Q2
0 quarters
|
|
191
Innoviz Technologies
INVZ
$82.6M
| $62.7K | 0.05% |
82,375
+60,323
| +274% | +$41.3K |
2026 Q1
1 quarter
|
|
192
INVO Fertility Inc
IVF
$1.51M
| $61.4K | 0.05% |
+32,338
| New | +$58.2K |
2026 Q2
0 quarters
|
|
193
Powerus Corporation Common Stock
PUSA
$261M
| $59.1K | 0.05% |
+14,804
| New | +$62.1K |
2026 Q2
0 quarters
|
|
194
Nano X Imaging
NNOX
$32.2M
| $58K | 0.05% |
+50,038
| New | +$94.2K |
2026 Q2
0 quarters
|
|
195
Kaixin Holdings
KXIN
$76.5M
| $56.9K | 0.05% |
+14,178
| New | +$78K |
2026 Q2
0 quarters
|
|
196
Whitehawk Therapeutics
WHWK
$172M
| $49.6K | 0.04% |
+10,838
| New | +$45.1K |
2026 Q2
0 quarters
|
|
197
Kiora Pharmaceuticals
KPRX
$10.5M
| $49.3K | 0.04% |
+18,746
| New | +$47.1K |
2026 Q2
0 quarters
|
|
198
Invivyd
IVVD
$180M
| $46.1K | 0.04% |
+52,893
| New | +$66.3K |
2026 Q2
0 quarters
|
|
199
Snap
SNAP
$10.6B
| $45.9K | 0.04% |
10,340
-22,092
| -68% | -$121K |
2026 Q1
1 quarter
|
|
200
Arq
ARQ
$77.7M
| $44.7K | 0.04% |
17,527
-17,101
| -49% | -$42.4K |
2026 Q1
1 quarter
|
|
Similar funds
AFP
BI
WCL
NIM
AF
AAA
WAT
FOTCLOO
Scientech Research LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Scientech Research LLC held 635 positions worth $123M, up 2.9% from $120M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Scientech Research LLC withdrew a net $13M in Q2 2026, closing 411 positions and reducing 22 holdings. Its most notable exit was Applied Digital, an estimated $1.63M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 20% a quarter earlier, followed by Healthcare and Miscellaneous.
Against the trend, Scientech Research LLC opened a new position in T-Rex 2X Long MSTR Daily Target ETF worth $1M.
- Scientech Research LLC's largest Q2 2026 buy was T-Rex 2X Long MSTR Daily Target ETF: 61,800 shares worth $1M.
- Scientech Research LLC added most to Tempus AI in Q2 2026, an estimated $1.43M increase.
- Scientech Research LLC's biggest Q2 2026 reduction was Unusual Machines, cutting an estimated $992K.
- Scientech Research LLC fully exited Applied Digital in Q2 2026, selling an estimated $1.63M.
- Scientech Research LLC's ten largest holdings make up 17% of its $123M portfolio in Q2 2026.
- Scientech Research LLC opened 186 new positions and closed 411 in Q2 2026.
- Scientech Research LLC's portfolio value rose 2.9% quarter-over-quarter to $123M.
Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.